|
|
|
|
|
|
|
|
|
|
|
|
|
FORM 4
| / X / | Check this box if no longer |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, D.C. 20549
STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP
Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934, Section 17(a) of the Public Utility Holding Company Act of 1935 or Section 30(f) of the Investment Company Act of 1940
1. Name and Address of Reporting Person
General Electric Company
2. Issuer Name and Ticker or Trading Symbol
OEC Medical Systems, Inc. (OXE)
3. IRS or Social Security Number of Reporting Person (Voluntary)
4. Statement for Month/Year
November 1999
5. If Amendment, Date of Original (Month/Year)
6. Relationship of Reporting Person(s) to Issuer (Check all applicable)
( ) Director |
( X ) 10% Owner |
( ) Officer (give title below) |
( ) Other (specify below) |
7. Individual or Joint/Group Filing (Check Applicable Line)
(X) Form filed by One Reporting Person
( ) Form filed by More than One Reporting Person
Table I -- Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
|
1. Title of Security |
2. Trans- |
3. Trans- |
4. Securities Acquired (A) or |
5. Amount of |
6. Ownership |
7. Nature of |
||||
|
Code |
V |
Amount |
(A) or (D) |
Price |
|
|||||
|
Common Stock |
11/29/99 |
J(1) |
12,724,415 |
A |
$36.00 (1) |
12,724,415 |
D |
|||
Reminder: Report on a separate line for each class of securities benefically owned directly or indirectly.
Table II -- Derivative Securitites Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
|
1. Title of Derivative |
2. Conversion |
3. Transaction |
4. Transaction |
5. Number of |
6. Date |
|||
| Code | V | (A) | (D) |
Date Exer- cisable |
Expira- tion Date |
|||
Table II (continued)
|
7. Title and Amount of Underlying Securities |
8. Price of Derivative Security |
9. Number of Derivative Securities Beneficially Owned at End of Month |
10. Ownership Form of Derivative Security Direct (D) or Indirect (I) |
11. Nature of Indirect Beneficial Ownership |
|
| Title |
Amount or Number of Shares |
||||
Explanation of Responses:
(1) The securities were acquired in connection with the closing of the Agreement and Plan of Merger Among General Electric Company ("GE"), Ruby Merger Corp. and OEC Medical Systems, Inc ("OEC") (the " Merger"). Upon the closing of the Merger, the shares of OEC stock were converted into the right to receive 0.262 shares of GE common stock and cash in lieu of fractional shares.
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations.
See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
/s/ Janet Bedol December 2, 1999
|
|